Wooree BioLtd Past Earnings Performance
Past criteria checks 2/6
Wooree BioLtd has been growing earnings at an average annual rate of 5.5%, while the Semiconductor industry saw earnings growing at 10% annually. Revenues have been declining at an average rate of 6.9% per year. Wooree BioLtd's return on equity is 4.6%, and it has net margins of 0.7%.
Key information
5.5%
Earnings growth rate
3.9%
EPS growth rate
Semiconductor Industry Growth | 23.5% |
Revenue growth rate | -6.9% |
Return on equity | 4.6% |
Net Margin | 0.7% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising
May 25Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative
Nov 29Recent updates
Does Wooree BioLtd (KOSDAQ:082850) Have A Healthy Balance Sheet?
Dec 16Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%
Oct 23Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%
Sep 07Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns
Aug 30Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up
Jul 19Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising
May 25These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too
Apr 26Should You Invest In Wooree BioLtd (KOSDAQ:082850)?
Feb 28Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 12Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain
Dec 21Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative
Nov 29Revenue & Expenses Breakdown
How Wooree BioLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,263,703 | 8,665 | 83,084 | 10,246 |
30 Jun 24 | 1,303,982 | 15,866 | 81,352 | 9,011 |
31 Mar 24 | 1,288,391 | 16,261 | 79,191 | 8,680 |
31 Dec 23 | 1,263,944 | 15,581 | 74,478 | 8,398 |
30 Sep 23 | 1,210,018 | 12,899 | 70,738 | 8,206 |
30 Jun 23 | 1,168,690 | 10,404 | 67,904 | 7,881 |
31 Mar 23 | 1,272,911 | 15,987 | 63,415 | 7,345 |
31 Dec 22 | 1,355,056 | 21,822 | 65,454 | 7,019 |
30 Sep 22 | 1,483,231 | 31,107 | 67,906 | 7,210 |
30 Jun 22 | 1,528,819 | 32,785 | 63,298 | 7,194 |
31 Mar 22 | 1,527,452 | 30,711 | 63,165 | 7,377 |
31 Dec 21 | 1,543,312 | 33,156 | 59,324 | 7,382 |
30 Sep 21 | 1,577,021 | 23,351 | 56,565 | 7,035 |
30 Jun 21 | 1,668,108 | 23,949 | 53,277 | 7,094 |
31 Mar 21 | 1,621,467 | 23,288 | 50,351 | 6,769 |
31 Dec 20 | 1,623,383 | 16,841 | 49,002 | 6,631 |
30 Sep 20 | 1,600,031 | 21,438 | 47,955 | 6,474 |
30 Jun 20 | 1,580,796 | 17,503 | 48,073 | 6,535 |
31 Mar 20 | 1,682,915 | 3,729 | 49,582 | 6,495 |
31 Dec 19 | 1,672,648 | 4,532 | 50,375 | 6,566 |
30 Sep 19 | 1,635,873 | -2,060 | 48,908 | 6,168 |
30 Jun 19 | 1,539,163 | -10,321 | 53,888 | 4,201 |
31 Mar 19 | 1,358,099 | -18,184 | 54,018 | 3,867 |
31 Dec 18 | 1,279,627 | -32,888 | 53,222 | 5,256 |
30 Sep 18 | 1,343,043 | -46,169 | 48,490 | 6,318 |
30 Jun 18 | 1,258,947 | -43,525 | 52,977 | 6,318 |
31 Mar 18 | 1,359,443 | -33,208 | 55,283 | 7,879 |
31 Dec 17 | 1,474,632 | -28,041 | 55,783 | 10,274 |
30 Sep 17 | 1,391,349 | -4,458 | 61,746 | 12,378 |
30 Jun 17 | 1,497,664 | -11,950 | 64,174 | 12,378 |
31 Mar 17 | 1,489,526 | -21,295 | 61,770 | 13,458 |
31 Dec 16 | 1,533,519 | -23,261 | 61,883 | 13,615 |
30 Sep 16 | 1,290,944 | -57,516 | 64,209 | 6,285 |
30 Jun 16 | 1,327,188 | -55,845 | 62,586 | 6,285 |
31 Mar 16 | 1,803,498 | -48,526 | 65,377 | 5,411 |
31 Dec 15 | 1,764,595 | -42,887 | 57,529 | 7,871 |
30 Sep 15 | 2,055,453 | -19,841 | 54,837 | 13,781 |
30 Jun 15 | 1,921,805 | -18,299 | 48,883 | 13,781 |
31 Mar 15 | 1,394,152 | -23,046 | 41,386 | 13,998 |
31 Dec 14 | 1,305,507 | -29,308 | 41,610 | 8,757 |
30 Sep 14 | 1,055,754 | -29,361 | 34,881 | 5,845 |
30 Jun 14 | 1,099,397 | -31,564 | 29,162 | 5,845 |
31 Mar 14 | 1,055,242 | -19,463 | 27,864 | 2,743 |
31 Dec 13 | 1,039,767 | -10,886 | 30,135 | 43 |
Quality Earnings: A082850 has high quality earnings.
Growing Profit Margin: A082850's current net profit margins (0.7%) are lower than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A082850 has become profitable over the past 5 years, growing earnings by 5.5% per year.
Accelerating Growth: A082850's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A082850 had negative earnings growth (-32.8%) over the past year, making it difficult to compare to the Semiconductor industry average (7.5%).
Return on Equity
High ROE: A082850's Return on Equity (4.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 16:11 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wooree Bio Co.,Ltd is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jonathan Rhee | Citigroup Inc |
Sang Hyeon Park | iM Securities |
Jong Woo Yoo | Korea Investment & Securities Co., Ltd. |